A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants

NCT02406261 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
82
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca

Collaborators